Is it more cost-effective for patients with chronic hepatitis b to have a trial of interferon before considering Nucleos(t)ide analogue therapy?
about
Is it more cost-effective for patients with chronic hepatitis b to have a trial of interferon before considering Nucleos(t)ide analogue therapy?
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Is it more cost-effective for ...... ucleos(t)ide analogue therapy?
@ast
Is it more cost-effective for ...... ucleos(t)ide analogue therapy?
@en
type
label
Is it more cost-effective for ...... ucleos(t)ide analogue therapy?
@ast
Is it more cost-effective for ...... ucleos(t)ide analogue therapy?
@en
prefLabel
Is it more cost-effective for ...... ucleos(t)ide analogue therapy?
@ast
Is it more cost-effective for ...... ucleos(t)ide analogue therapy?
@en
P2860
P1476
Is it more cost-effective for ...... ucleos(t)ide analogue therapy?
@en
P2093
Anna S Lok
Monica A Konerman
P2860
P304
P356
10.1016/J.CGH.2014.08.024
P407
P577
2014-08-23T00:00:00Z